Trump-Era Pharmaceutical Tariff Exemptions for EU, Japan Recalled
Trump-Era Pharmaceutical Tariff Exemptions for EU, Japan Recalled During his presidency, Donald Trump’s administration established new tariffs on pharmaceutical imports, though these duties were not uniformly applied across all nations. Countries with pre-existing trade agreements with the United States that included specific drug provisions, such as the European Union and Japan, were granted exemptions or reduced rates. White House officials at the time confirmed that duties on pharmaceuticals from the EU would be capped at 15% under their framework deal,…